Today: 24 May 2026
Browse Category

NYSE:BHVN 13 August 2025 - 3 November 2025

Biohaven Stock’s Wild Ride: Big Drops, Big Hopes as FDA Verdict Nears

Biohaven Stock’s Wild Ride: Big Drops, Big Hopes as FDA Verdict Nears

Biohaven Ltd. shares dropped over 20% in pre-market trading Nov. 3, falling to about $13.40 after closing at $17.20 on Oct. 31. The decline comes ahead of an FDA decision on troriluzole, expected in Q4 2025. The stock is down roughly 66% year-over-year, far underperforming biotech peers. Biohaven reported $408 million in cash mid-2025 but posted a $198 million net loss in Q2.
3 November 2025
·
Breakthrough Drug Approved, Billion-Dollar Deals & Outbreak Alerts – Global Biotech & Health Roundup (Aug 12–13, 2025)

Breakthrough Drug Approved, Billion-Dollar Deals & Outbreak Alerts – Global Biotech & Health Roundup (Aug 12–13, 2025)

The FDA approved brensocatib (Brinsupri) as the first treatment for non-cystic fibrosis bronchiectasis, affecting about 500,000 Americans. Novartis reported positive Phase 3 results for ianalumab in Sjögren’s syndrome and immune thrombocytopenia. Biohaven’s OCD drug troriluzole failed in late-stage trials. Cardinal Health will acquire Solaris Health for $1.9 billion in cash.
13 August 2025
···

Stock Market Today

  • OneSpaWorld Holdings (OSW) Valuation Analysis Amid Share Price Gains and Growth Prospects
    May 24, 2026, 3:24 AM EDT. OneSpaWorld Holdings (OSW) shares closed at US$23.99, showing a 10.8% return over 90 days and a 30.8% total return over one year. The stock is considered 14.3% undervalued with a fair value estimate of US$28, driven by expectations of improved operational efficiency and revenue growth from AI and technology initiatives by 2026. Despite this optimism, the company's price-to-earnings (P/E) ratio of 31.4x exceeds the Consumer Services industry average of 16.2x, raising valuation risk concerns. Investors should weigh the potential of sustained cruise demand and technology adoption against this premium to make informed decisions.

Latest articles

Nifty Faces Oil Moves, Rupee and Short Week

Nifty Faces Oil Moves, Rupee and Short Week

24 May 2026
The Nifty 50 rose 0.27% Friday to 23,719.3 and the Sensex gained 0.31% to 75,415.35, but both indexes remain down sharply since the Iran war began. The rupee hit record lows, prompting Reserve Bank intervention, and foreign investors have sold $23 billion in Indian shares this year. Markets will close Thursday for Bakri Id, leaving four trading sessions in the week.
Australia Stock Market Today: ASX 200 Stalls Near 9,000 as NAB Slides, Oil Shock Keeps Traders on Edge. (Indo Premier)

ASX on Watch as Inflation Test Looms After Volatile Week

24 May 2026
The ASX 200 closed up 0.41% at 8,657 on Friday, gaining 0.3% for the week after volatile trading. Investors await April inflation data due Wednesday, seen as key for Reserve Bank of Australia rate expectations after weak April jobs figures cooled rate-hike bets. The Australian dollar traded at 71.36 U.S. cents late Friday. Miners and energy stocks led gains, while consumer and telecom shares fell.
FTSE 100 Today: BP Rally Lifts UK Stocks as Barclays and Taylor Wimpey Fall

UK stocks steady as rate fears ease, but FTSE 100 faces Iran, retail in coming week

24 May 2026
The FTSE 100 rose 2.66% last week, ending a four-week losing streak as traders scaled back expectations for a near-term Bank of England rate hike. Retail sales volumes fell 1.3% in April, and the UK composite PMI dropped to 48.5 in May. The London Stock Exchange is closed Monday for the Spring Bank Holiday. Bodycote shares jumped 19% after a £1.52 billion takeover proposal from Apollo.
Go toTop